Related references
Note: Only part of the references are listed.The circulating microRNome demonstrates distinct lymphocyte subset-dependent signatures
Paola de Candia et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b
H. Yang et al.
ONCOGENE (2016)
The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1
Yanhui Jiang et al.
TUMOR BIOLOGY (2016)
Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls A Multicenter Study
Jianwei Xu et al.
ANNALS OF SURGERY (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSFIOA-related manner
Shangyou Zheng et al.
CANCER LETTERS (2016)
Current standards and new innovative approaches for treatment of pancreatic cancer
Thierry Conroy et al.
EUROPEAN JOURNAL OF CANCER (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Unique features of long non-coding RNA biogenesis and function
Jeffrey J. Quinn et al.
NATURE REVIEWS GENETICS (2016)
Circulating MicroRNAs as Biomarkers for Sepsis
Fabian Benz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer
Mahito Miyamae et al.
BRITISH JOURNAL OF CANCER (2015)
microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis
Adam E. Frampton et al.
EUROPEAN JOURNAL OF CANCER (2015)
Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma
Shuhei Komatsu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Long Noncoding RNA MALAT-1 Enhances Stem Cell-Like Phenotypes in Pancreatic Cancer Cells
Feng Jiao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma
Yibiao Ye et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer
Zhihua Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Evaluation of the Fukuoka Consensus Guidelines for intraductal papillary mucinous neoplasms of the pancreas: Results from a systematic review of 1,382 surgically resected patients
Brian K. P. Goh et al.
SURGERY (2015)
Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer
Yue Zhao et al.
TARGETED ONCOLOGY (2015)
The Landscape of long noncoding RNA classification
Georges St Laurent et al.
TRENDS IN GENETICS (2015)
miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases
Qinhong Xu et al.
ONCOTARGET (2015)
The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration
Yating Cheng et al.
ONCOTARGET (2015)
Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury
A. D. B. Vliegenthart et al.
SCIENTIFIC REPORTS (2015)
miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop
Y. Zhang et al.
BRITISH JOURNAL OF CANCER (2015)
Salivary microRNAs Show Potential as a Noninvasive Biomarker for Detecting Resectable Pancreatic Cancer
Zijun Xie et al.
CANCER PREVENTION RESEARCH (2015)
miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer
F. Lahdaoui et al.
ONCOGENE (2015)
miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma
W. Gao et al.
ONCOGENE (2015)
MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes
I. Keklikoglou et al.
ONCOGENE (2015)
Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer
Er-Jun Pang et al.
TUMOR BIOLOGY (2015)
Microarray expression profile of circular RNAs in human pancreatic ductal adenocarcinoma
Shibin Qu et al.
GENOMICS DATA (2015)
A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select miRNA in Plasma and Bile
Gregory A. Cote et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
A Differential MicroRNA Profile Distinguishes Cholangiocarcinoma from Pancreatic Adenocarcinoma
Amy L. Collins et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer
Anupama Mittal et al.
BIOMATERIALS (2014)
A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1α in pancreatic ductal adenocarcinoma
Y-W Sun et al.
BRITISH JOURNAL OF CANCER (2014)
MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression
Adam E. Frampton et al.
GASTROENTEROLOGY (2014)
Down-regulation of MicroRNA-494 via Loss of SMAD4 Increases FOXM1 and β-Catenin Signaling in Pancreatic Ductal Adenocarcinoma Cells
Lei Li et al.
GASTROENTEROLOGY (2014)
MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
Nicolai A. Schultz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Stromal MicroRNA-21 Levels Predict Response to 5-Fluorouracil in Patients With Pancreatic Cancer
Timothy R. Donahue et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
William Greenhalf et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
Brian M. Wolpin et al.
NATURE GENETICS (2014)
Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer
Wei Peng et al.
MEDICAL ONCOLOGY (2014)
microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions
H. Ouyang et al.
ONCOGENE (2014)
Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1
P. Wang et al.
ONCOGENE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
MicroRNA-196a and-196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer
Emily P. Slater et al.
TRANSLATIONAL ONCOLOGY (2014)
H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT
Chenchao Ma et al.
TUMOR BIOLOGY (2014)
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms
S. Caponi et al.
ANNALS OF ONCOLOGY (2013)
Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
T. Kawaguchi et al.
BRITISH JOURNAL OF CANCER (2013)
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
Todd M. Bauer et al.
CANCER (2013)
Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6
Xiongxiong Lu et al.
CELL AND TISSUE RESEARCH (2013)
Serum miR-1290 as a Marker of Pancreatic Cancer-Response
Ang Li et al.
CLINICAL CANCER RESEARCH (2013)
Distinct miRNA profiles are associated with malignant transformation of pancreatic cystic tumors revealing potential biomarkers for clinical use
Adam E. Frampton et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2013)
Circulating microRNAs (miRs) for diagnosing acute myocardial infarction: An exciting challenge
Fabiola Olivieri et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Targeting miR-21 for the Therapy of Pancreatic Cancer
Flavie Sicard et al.
MOLECULAR THERAPY (2013)
Circular RNAs are a large class of animal RNAs with regulatory potency
Sebastian Memczak et al.
NATURE (2013)
Treatment of HCV Infection by Targeting MicroRNA
Harry L. A. Janssen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer
K. Kim et al.
ONCOGENE (2013)
MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm
Yue Xue et al.
CANCER GENETICS (2013)
U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis
Fabian Benz et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Biomarkers in Pancreatic Cancer Diagnostic, Prognostic, and Predictive
Zhi Ven Fong et al.
CANCER JOURNAL (2012)
miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells
Hai-jiao Yan et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Genome-wide analysis of long noncoding RNA stability
Michael B. Clark et al.
GENOME RESEARCH (2012)
Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer
Jianqiang Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells
Lei You et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis
Xiangyu Kong et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus-Related Hepatocellular Carcinoma
Jian Zhou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice
Dipankar Pramanik et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis
Kohei Nakata et al.
SURGERY (2011)
Regulation of mRNA Translation and Stability by microRNAs
Marc Robert Fabian et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
Elisa Giovannetti et al.
CANCER RESEARCH (2010)
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
Nils Habbe et al.
CANCER BIOLOGY & THERAPY (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Evolution and Functions of Long Noncoding RNAs
Chris P. Ponting et al.
CELL (2009)
let-7 MicroRNA Transfer in Pancreatic Cancer-Derived Cells Inhibits In Vitro Cell Proliferation but Fails to Alter Tumor Progression
Jerme Torrisani et al.
HUMAN GENE THERAPY (2009)
Antisense Inhibition of microRNA-21 or-221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
Jong-Kook Park et al.
PANCREAS (2009)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development
Meritxell Gironella et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma
A. E. Szafranska et al.
ONCOGENE (2007)
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
Mark Bloomston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Expression profiling identifies microRNA signature in pancreatic cancer
Eun Jon Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior
Claudia Roldo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
RAS is regulated by the let-7 MicroRNA family
SM Johnson et al.
CELL (2005)
Share Paper
